Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia

Blood

Volumn 98, Issue 10, 2001, Pages 2917-2921

  Croop, James M ^a,b,c,d,e   Cooper, Ryan ^a,b,c,d,e   Fernandez, Christine ^a,b,c,d,e   Graves, Vicki ^a,b,c,d,e   Kreissman, Susan ^a,b,c,d,e   Hanenberg, Helmut ^a,b,c,d,e   Smith, Franklin O ^a,b,c,d,e   Williams, David A ^a,b,c,d,e  

^a Department of Pediatrics   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

^c Department of Pathology   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CELL COUNT; BONE MARROW DEPRESSION; CASE REPORT; CHEMOTHERAPY; CRYOPRESERVATION; DISEASE COURSE; FANCONI ANEMIA; FEMALE; GENE THERAPY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; MALE; PANCYTOPENIA; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0035892134     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.10.2917     Document Type: Article

References (39)

1. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood, 5th ed. Philadelphia, PA: W. B. Saunders; 1997:227-335.
2. D'Andrea AD, Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood. 1997;90:1725-1736.
3. Alter BP. Fanconi anemia and malignancies. Am J Hematol. 1996;53:99-110.
4. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients: a review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991;51:1-12.
5. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol. 1993;21:731-733.
6. Daneshbod-Skibba G, Martin J, Shahidi NT. Myeloid and erythroid colony growth in non-anaemic patients with Fanconi's anaemia. Br J Haematol. 1980;44:33-38.
7. Alter BP, Knobloch ME, Weinberg RS. Erythropoiesis in Fanconi anemia, Blood. 1991;78:602-608.
8. Joenje H, Levitus M, Waisfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet. 2000;67:759-762.
9. Fanconi anaemia/breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene. Nat Genet. 1996;14:324-328.
10. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet. 1996;14:320-323.
11. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992;358:763-767.
12. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet. 1998;20:281-283.
13. de Winter JP, Rooimans MA, van Der Weel L, et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24:15-16.
14. de Winter JP, Leveille F, van Berkel CG, et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet. 2000;67:1306-1308.
15. Garcia-Higuera I, Kuang Y, D'Andrea AD. The molecular and cellular biology of Fanconi anemia. Curr Opin Hematol. 1999;6:83-88.
16. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241-248.
17. Hejna JA, Timmers CD, Reifsteck C, et al. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3. Am J Hum Genet. 2000;66:1540-1551.
18. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7:249-262.
19. Haneline LS, Gobbett TA, Ramani R, et al. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999;94:1-8.
20. Battaile KP, Bateman RL, Mortimer D, et al. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. Blood. 1999;94:2151-2158.
21. Shahidi N, Crigler J. Evaluation of growth and of ednocrine systems in testosterone-corticosteroid-treated patients with aplastic anemia. J Pediatr. 1967;70:233-237.
22. Shahidi N, Diamond L. Testosteron-induced remission in aplastic anemia. Am J Dis Child. 1959;98:293-297.
23. Rackoff WR, Orazi A, Robinson CA, et al. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study. Blood. 1996;88:1588-1593.
24. Lopez KD, Guinan EC. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia. Pediatr Nurs. 1995;21:345-349.
25. Kemahli S, Canatan D, Uysal Z, et al. GM-CSF in the treatment of Fanconi's anaemia. Br J Haematol. 1994;87:871-872.
26. Butturini A, Gale RP, Verlander PC, et al. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994;84:1650-1655.
27. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95:422-429.
28. Harris RE. Reduction of toxicity of marrow transplantation in children with Fanconi anemia [comment]. J Pediatr Hematol Oncol. 1999;21:175-176.
29. Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant. 1999;24:849-852.
30. Zwaan CM, Van Weel-Sipman MH, Fibbe WE, Oudshoorn M, Vossen JM. Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience. Bone Marrow Transplant. 1998;21:447-453.
31. Yule SM, Price L, Cole M, Pearson AD, Boddy AV. Cyclophosphamide metabolism in children with Fanconi's anaemia. Bone Marrow Transplant. 1999;24:123-128.
32. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54:431-440.
33. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392.
34. Giampietro PF, Verlander PC, Davis JG, Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malformations: an international Fanconi Anemia Registry Study. Am J Med Genet. 1997;68:58-61.
35. Mavroudis D, Read E, Cottler-Fox M, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996;88:3223-3229.
36. Croop JM, Cooper, R., Seshadri R, et al. Large scale mobilization and isolation of CD34+ cells from normal donors. Bone Marrow Transplant. 2000;26:1271-1279.
37. Guinan EC, Lopez KD, Huhn RD, Felser JM, Nathan DG. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with Fanconi anemia. J Pediatr. 1994;124:144-150.
38. Gillio AP, Gabrilove JL. Cytokine treatment of inherited bone marrow failure syndromes. Blood. 1993;81:1669-1674.
39. Liu JM, Kim S, Read EJ, et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther. 1999;10:2337-2346.